
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. (COGT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COGT · as of Jun 8, 2026
Key Statistics
Explore Cogent Biosciences, Inc. Data
cogt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The COGT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $49.17, representing +58.51% upside from the current price of $31.02.
Competitors & Peers
cogt competitorsStock Performance
Full HistoryAbout Cogent Biosciences, Inc.
Cogent Biosciences, Inc. a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase …
what is cogent biosciences, inc. · cogt stock overview · cogent biosciences, inc. company profile · who is cogent biosciences, inc. ceo · cogt NASDAQ · cogent biosciences, inc. headquarters · cogent biosciences, inc. business segments
About Stock Overview & Key Data
Cogent Biosciences, Inc. (COGT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 29, 2018. As of the latest trading session, COGT stock price is $31.02, with a market capitalization of $5.3B. The stock has returned +349.57% over the past 12 months and -12.67% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Cogent Biosciences, Inc. stock is Buy, with an average 12-month price target of $49.17. In fiscal year 2025, Cogent Biosciences, Inc. reported revenue of — and net income of -$328.9M. For detailed data — including Cogent Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cogent Biosciences, Inc. (COGT) stock price is $31.02. The stock is traded on NASDAQ under the ticker symbol COGT. The 52-week range is $5.49 – $43.73.